Hypertension and atherosclerosis in cholesterol-fed rabbits. Part 1. Mild, two-kidney, one-clip goldblatt hypertension treated with enalapril

Atherosclerosis

Volumn 59, Issue 3, 1986, Pages 283-299

  Overturf, Merrill ^a   Sybers, Harley ^a   Schaper, Jutta ^b   Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Aorta; Atherosclerosis; Blood chemistry; Blood pressure; Cholesterol; Enalapril; Heart; Kidney

Indexed keywords

CHOLESTEROL; ENALAPRIL;

ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DIET; DRUG EFFICACY; HYPERTENSION; KIDNEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

ANIMAL; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; ENALAPRIL; HYPERTENSION, RENOVASCULAR; LIPOPROTEINS; MALE; MICROSCOPY, ELECTRON; MYOCARDIUM; ORGAN WEIGHT; RABBITS; RENIN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022632212     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(86)90124-3     Document Type: Article

References (57)

1. The relationship between experimental hypertension and cholesterol induced atheroma in rabbits
2. Effect of experimental renal hypertension on experimental thiouracilcholesterol atherosclerosis in dogs
3. Rapid acceleration of atherosclerosis in hypertensive rats on high rat diet
4. Deleterious effects of hypertension on the development of aortic and coronary atherosclerosis diet
5. Aggravation of atherosclerosis by hypertension in a subhuman primate model of coarctation of the aorta
6. Left ventricular hypertrophy in hypertension — The Framingham Study
7. Effects of treatment on morbidity in hypertension Part 3 (Influence of age diastolic pressure and prior cardiovascular disease — Further analysis of side effects)
8. Five-year findings of the Hypertension Detection and Follow-up Program Reduction in mortality of persons with high blood pressure including mild hypertension
9. Hemodynamic modification of aortic atherosclerosis
10. Morphologic and functional changes of the aortic interior during experimental hypertension
11. Evolution of aortic hyperplasia after reversal of renovascular hypertension in the rat
12. Blood pressure lowering diminishes age-related changes in the rat aortic intima
13. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
14. The beta-blocker heart attacks trial
15. Effect of propranolol and prazosin on blood lipids
16. Risk factor changes and mortality results
17. Should mild hypertension be treated?
18. Mild Hypertension, when and how to treat it
19. Therapy of mild hypertension — An overview
20. Cholesterol vehicle in experimental atherosclerosis Part 4 (Influence of heated fat and fatty acids)
21. The renal circulation in experimental hypertension
22. Indirect blood pressure measurements in the rabbit — Correlations with direct aortic and ear pressures
23. Effects of renal artery constriction and subsequent contralateral nephrectomy on the blood pressure, plasma renin activity and renin substrate concentration in rabbits
24. Renin as a risk factor for atherogenesis — Effects of hypercholesterolemia and two-kidney-one-clip hypertension in the rabbit
25. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects
26. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I
27. Human angiotensinogen
28. A simple radioassay for angiotensin converting enzyme
29. Electrophoretic separation of plasma lipoproteins in agarose gel
30. Polyacrylamide gel disc electrophoresis as a screening procedure for serum lipoprotein abnormalities
31. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel
32. Protein measurement with the Folin phenol reagent
33. A simple method for the isolation and purification of total lipids from animal tissues
34. Enzymatic determination of total serum cholesterol
35. Triglycerides — Determination after enzymatic hydrolysis
36. Comparison of methods for quantitating bronchial morphology
37. Renin as a risk factor for atherogenesis, Part 2 (Effects of hypercholesterolemia and hyporeninemia in the rabbit)
38. Renin as a risk factor for atherogenesis, Part 3 (Effects of hypercholesterolemia, hyporeninemia and onekidney, one-clip hypertension in the rabbit
39. Haemolytic anemia in cholesterol-fed rabbits
40. Capoten-induced juxtaglomerular hyperplasia in rabbits
41. Mechanisms of deterioration in renal function in patients with renovascular hypertension treated with enalapril
42. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril
43. Contracting renal effects of different antihypertensive agents in hypertensive rats with bilaterally constricted renal arteries
44. Plasma vasopressin concentrations of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension
45. Effect of removing the clipped kidney on renovascular hypertension in rabbits
46. Pathogenic factors underlying the beneficial effects of high sodium intake in experimental renovascular hypertension
47. Antihypertensive activity of N-(S)-1-(ethoxycarbonyl)-3-phenylprophyl-t-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor
48. The clinical application of converting enzyme inhibitors
49. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (Enalapril)
50. Non-sulphydryl-containing angiotensin-converting enzyme inhibitor (MK-421) — Evidence for a role of renin system in normotensive subjects
51. Reflexhemodynamic adjustments and baroflex sensitivity during converting enzyme inhibition with MK-421 in normal humans
52. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension
53. The Veterans trial and sequelae
54. Hypertrophy in the human heart